Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Medical University of Vienna: New therapy option doubles the life span of B-cell lymphoma patients

infusion © pixabay

The so-called CAR-T cell therapy is a promising option for treating around one fifth of patients with diffuse large B-cell lymphoma.

That is the main finding of the multi-center JULIET study, in which researchers from the Comprehensive Cancer Centre (CCC) of the Medical University of Vienna and Vienna General Hospital participated. In CAR-T cell therapy, previously modified T-cells recognize a specific protein on the surface of the tumor. This in turn triggers destruction of the tumor cells. This introduces a new option for treating such patients. This is because the two-year survival rate following standard treatment is only 20 percent, whereas, with CAR-T cell therapy, overall survival has doubled to 40%. The results of this study were published in the New England Journal of Medicine.

Read more:

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • ESIB 2019

    18. - 20.11.2019, Graz, Austria

Austria Map

Find the perfect location for your company
Storage and distribution for Eastern Europe is more economical from Vienna than from Prague or Budapest. Because shipping business between the individual reform nations is barely developed, whereas neary every Eastern destination is serviced from Vienna several times a week.

Hewlett Packard Austria

Logo
More testimonials

news from the business location Austria

Unexpected role of mTORC2 protein in colorectal cancer

New results from researchers at the Centre for Pathobiochemistry and Genetics at the Medical University of Vienna show that a protein called mTORC2, which is the target of newly developed cancer drugs, is not even active in colorectal cancer.

Insider Tip: FinTech Location Vienna

Startups and key players on the scene will gather together at the upcoming Fintech Week Vienna (18 – 24 November 2019) with the European Fintech Summit on 19 November as the highlight. Vienna, which is (still) underestimated as a European FinTech hotspot, not only spawns its own world-renowned start-ups but also attracts international FinTech companies.

More news All blog posts